News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,271 Results
Type
Article (60975)
Company Profile (91)
Press Release (643205)
Multimedia
Podcasts (99)
Webinars (12)
Section
Business (198080)
Career Advice (3003)
Deals (34630)
Drug Delivery (108)
Drug Development (80986)
Employer Resources (172)
FDA (16051)
Job Trends (15043)
News (338891)
Policy (32609)
Tag
Academia (2820)
Academic (2)
Accelerated approval (6)
Adcomms (25)
Allergies (91)
Alliances (49789)
ALS (93)
Alzheimer's disease (1396)
Antibody-drug conjugate (ADC) (126)
Approvals (16050)
Artificial intelligence (284)
Autoimmune disease (23)
Automation (16)
Bankruptcy (315)
Best Places to Work (11610)
BIOSECURE Act (20)
Biosimilars (110)
Biotechnology (60)
Bladder cancer (80)
Brain cancer (29)
Breast cancer (282)
Cancer (2285)
Cardiovascular disease (182)
Career advice (2542)
Career pathing (34)
CAR-T (164)
Cell therapy (458)
Cervical cancer (21)
Clinical research (65679)
Collaboration (849)
Compensation (369)
Complete response letters (22)
COVID-19 (2669)
CRISPR (44)
C-suite (263)
Cystic fibrosis (104)
Data (2208)
Decentralized trials (2)
Denatured (35)
Depression (44)
Diabetes (270)
Diagnostics (6428)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (129)
Drug pricing (108)
Drug shortages (27)
Duchenne muscular dystrophy (92)
Earnings (76195)
Editorial (42)
Employer branding (21)
Employer resources (150)
Events (107281)
Executive appointments (767)
FDA (17344)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (763)
Gene editing (110)
Generative AI (28)
Gene therapy (320)
GLP-1 (738)
Government (4767)
Grass and pollen (6)
Guidances (65)
Healthcare (19126)
Huntington's disease (19)
IgA nephropathy (25)
Immunology and inflammation (122)
Indications (30)
Infectious disease (2810)
Inflammatory bowel disease (143)
Inflation Reduction Act (10)
Influenza (54)
Intellectual property (99)
Interviews (572)
IPO (15822)
IRA (44)
Job creations (3849)
Job search strategy (2120)
Kidney cancer (10)
Labor market (33)
Layoffs (526)
Leadership (24)
Legal (7805)
Liver cancer (75)
Lung cancer (322)
Lymphoma (152)
Machine learning (7)
Management (58)
Manufacturing (303)
MASH (67)
Medical device (13273)
Medtech (13278)
Mergers & acquisitions (19393)
Metabolic disorders (692)
Multiple sclerosis (82)
NASH (18)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1938)
NextGen: Class of 2025 (6778)
Non-profit (4668)
Now hiring (16)
Obesity (359)
Opinion (257)
Ovarian cancer (74)
Pain (93)
Pancreatic cancer (82)
Parkinson's disease (148)
Partnered (22)
Patents (243)
Patient recruitment (115)
Peanut (51)
People (60676)
Pharmaceutical (24)
Pharmacy benefit managers (17)
Phase I (20498)
Phase II (28826)
Phase III (21441)
Pipeline (1190)
Policy (149)
Postmarket research (2774)
Preclinical (8828)
Press Release (68)
Prostate cancer (111)
Psychedelics (33)
Radiopharmaceuticals (258)
Rare diseases (390)
Real estate (6310)
Recruiting (69)
Regulatory (22199)
Reports (40)
Research institute (2537)
Resumes & cover letters (461)
Rett syndrome (5)
RNA editing (5)
RSV (41)
Schizophrenia (71)
Series A (137)
Series B (85)
Service/supplier (10)
Sickle cell disease (54)
Special edition (12)
Spinal muscular atrophy (154)
Sponsored (31)
Startups (3514)
State (1)
Stomach cancer (12)
Supply chain (66)
Tariffs (31)
The Weekly (62)
Vaccines (720)
Venture capitalists (39)
Weight loss (242)
Women's health (33)
Worklife (20)
Date
Today (170)
Last 7 days (885)
Last 30 days (2606)
Last 365 days (32280)
2025 (10779)
2024 (34373)
2023 (38733)
2022 (49496)
2021 (54622)
2020 (53634)
2019 (47441)
2018 (36009)
2017 (32984)
2016 (32808)
2015 (38413)
2014 (32114)
2013 (28446)
2012 (29712)
2011 (29558)
2010 (28292)
Location
Africa (978)
Alabama (58)
Alaska (7)
Arizona (186)
Arkansas (14)
Asia (41224)
Australia (7286)
California (5803)
Canada (1958)
China (532)
Colorado (266)
Connecticut (283)
Delaware (147)
Europe (95250)
Florida (888)
Georgia (211)
Idaho (57)
Illinois (563)
India (27)
Indiana (303)
Iowa (9)
Japan (156)
Kansas (101)
Kentucky (26)
Louisiana (11)
Maine (63)
Maryland (879)
Massachusetts (4325)
Michigan (224)
Minnesota (366)
Mississippi (2)
Missouri (88)
Montana (30)
Nebraska (23)
Nevada (60)
New Hampshire (63)
New Jersey (1731)
New Mexico (30)
New York (1728)
North Carolina (1001)
North Dakota (8)
Northern California (2527)
Ohio (199)
Oklahoma (15)
Oregon (35)
Pennsylvania (1301)
Puerto Rico (11)
Rhode Island (30)
South America (1316)
South Carolina (22)
South Dakota (1)
Southern California (2208)
Tennessee (101)
Texas (881)
United States (22441)
Utah (183)
Virginia (143)
Washington D.C. (60)
Washington State (535)
West Virginia (3)
Wisconsin (59)
704,271 Results for "institute of bioengineering and nanotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess™ and Other Bioengineered Tissues
February 27, 2025
·
6 min read
Press Releases
Cell BioEngines Announces Establishment of New R&D Facility to Further Advance Its Platform and Pipeline of Innovative Cell Therapies
January 21, 2025
·
5 min read
Pharm Country
Cell BioEngines to Present at the 2024 BIO CEO & Investor Conference
Cell BioEngines, Inc. announced that Dr. Ajay Vishwakarma, Founder and CEO of Cell BioEngines, will be presenting at the BIO CEO & Investor Conference at 2:00 p.m. EST on Monday, February 26, 2024.
February 8, 2024
·
2 min read
Press Releases
Andelyn Biosciences Expands AAV Curator™ Platform Offering to Include Stanton Lab CNS Capsids through a License Agreement from the Broad Institute of MIT and Harvard
February 19, 2025
·
3 min read
DNA Nanotechnology Market Expected to Grow at a CAGR of 24.67% from 2024 to 2031
Global DNA Nanotechnology Market is valued at US$ 4.34 Bn in 2023, and it is expected to reach US$ 24.29 Bn by 2031, with a CAGR of 24.67% during the forecast period of 2024-2031.
April 22, 2024
·
4 min read
BioCapital
Pantheon Vision Secures a Second Tranche of $1.8 Million to Advance Bioengineered Corneal Implants
Pantheon Vision Secures a Second Tranche of $1.8 Million to Advance Bioengineered Corneal Implants.
April 2, 2024
·
2 min read
Immutep successfully completes institutional placement and institutional component of entitlement offer
Immutep Limited ACN 009 237 889 is pleased to announce the successful completion of its institutional placement and the institutional component of its 1 for 16 pro rata accelerated non-renounceable entitlement offer of new fully paid ordinary shares in Immutep.
June 5, 2024
·
7 min read
Press Releases
Karen Knudsen, MBA PhD, Appointed Chief Executive Officer of the Parker Institute for Cancer Immunotherapy
April 1, 2025
·
7 min read
Press Releases
Nanocarry Therapeutics’ Brain Penetrating Nanoplatform Selected by the NCI Nanotechnology Characterization Laboratory for its Preclinical Characterization Program
September 5, 2024
·
3 min read
Press Releases
Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
April 21, 2025
·
4 min read
1 of 70,428
Next
